Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
This is unchanged from the number of companies cited in the previous year.
Of the 20 citations issued, the most common citation was 'Document control procedures have not been adequately established'.
Most of the companies cited were involved in the Devices sector. The second most common type of company cited in the time period worked in the the Biologics sector.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Allison Medical, Inc. | Devices | 04/28/2023 | Files do not contain copies of MDR reports |
Allison Medical, Inc. | Devices | 04/28/2023 | Procedures not adequately established or maintained |
Allison Medical, Inc. | Devices | 04/28/2023 | Software validation for automated processes |
Allison Medical, Inc. | Devices | 04/28/2023 | Lack of or inadequate procedures |
AlloSource | Biologics | 03/30/2023 | Clean, sanitary, orderly manner |
AlloSource | Biologics | 03/30/2023 | Validation & approval--established procedures |
CoRE labs, LLC | Devices | 06/21/2023 | Design changes - Lack of or Inadequate Procedures |
CoRE labs, LLC | Devices | 06/21/2023 | Procedures not adequately established or maintained |
CoRE labs, LLC | Devices | 06/21/2023 | Nonconforming product, Lack of or inadequate procedures |
CoRE labs, LLC | Devices | 06/21/2023 | Lack of or inadequate complaint procedures |
D. O. Weaver and Company | Devices | 05/12/2023 | Lack of or inadequate process validation |
D. O. Weaver and Company | Devices | 05/12/2023 | Records of MDR Investigation |
Lewis, Karl D., M.D. | Biologics | 08/07/2023 | Copy of consent form not provided |
Lewis, Karl D., M.D. | Biologics | 08/07/2023 | FD-1572, protocol compliance |
Lewis, Karl D., M.D. | Biologics | 08/07/2023 | Case history records- inadequate or inadequate |
Share Good Foods, Inc. | Food and Cosmetics | 02/23/2023 | Qualifications of individuals |
Share Good Foods, Inc. | Food and Cosmetics | 02/23/2023 | Personnel |
Share Good Foods, Inc. | Food and Cosmetics | 02/23/2023 | Cleaning and sanitizing substances - Safe and adequate |
Share Good Foods, Inc. | Food and Cosmetics | 02/23/2023 | Pest control |
Share Good Foods, Inc. | Food and Cosmetics | 02/23/2023 | Manufacturing, processing, packing, holding - Controls |